Penny Asbell
Ophthalmology · Memphis, TNNPI 1063473387
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $104,364 of the $130,746 with a category attached, or 79.8%. Regeneron accounts for 70.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2020 at $53,462 and has fallen 87.4% since, to $6,732 in 2025. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $787.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$92K
- Amgen$13K
- AbbVie$4K
- Dompe Farmaceutici S.p.a.$4K
- Harrow Eye, LLC$3K
- Kala Pharmaceuticals, Inc.$2K
- plus $12K from 15 others
Across 26 payments — averaging $1374.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$30K
- Kowa Research Institute, Inc.$6K
What the payments were for
- Consulting fees$104,36480%
- Speaking & faculty fees$8,8007%
- Travel & lodging$11,6259%
- Food & beverage$4,7804%
- Education$1370%
- Gifts$1,0401%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 70 | $92,381 |
| Amgen(2 entities) | 20 | $12,587 |
| AbbVie | 6 | $4,157 |
| Dompe Farmaceutici S.p.a. | 2 | $3,752 |
| Harrow Eye, LLC | 7 | $3,193 |
| Kala Pharmaceuticals, Inc. | 3 | $2,288 |
| Bausch & Lomb Americas Inc. | 13 | $2,095 |
| Astrazeneca UK Limited | 3 | $2,014 |
| Recordati_rare_diseases_inc. | 3 | $1,898 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $1,648 |
| Eyepoint US, Inc. | 2 | $1,317 |
| Dompe US, Inc. | 10 | $1,164 |
| Shire North American Group Inc | 3 | $961 |
| Sun Pharmaceutical Industries Inc. | 8 | $416 |
| Alcon | 4 | $373 |
| Thea Pharma Inc. | 3 | $200 |
| Tarsus Pharmaceuticals, Inc. | 2 | $168 |
| Novartis | 1 | $50 |
| Sight Sciences, Inc. | 1 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Quidel Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$130,746 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Memphis
- Melissa ToyosMemphis$1.3M
- Rolando ToyosMemphis$809K
- Brian FowlerMemphis$206K
- Brian JerkinsMemphis$150K
- James FreemanMemphis$141K
- John FreemanMemphis$136K
- Kourtney HouserMemphis$104K
- Subba GollamudiMemphis$67K
- Andrew CrothersMemphis$13K
- Brian SmithMemphis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.